AstraZeneca Pharma India Limited (ASTRAZEN.BO)
INR 6485.35
(0.07%)
INR 6485.35
(0.07%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 12.95 Billion | 10.02 Billion | 8.05 Billion | 8.08 Billion | 8.31 Billion | 7.06 Billion |
| Cost of Revenue | 6.73 Billion | 4.25 Billion | 3.57 Billion | 3.3 Billion | 3.34 Billion | 2.69 Billion |
| Gross Profit | 6.22 Billion | 5.77 Billion | 4.48 Billion | 4.78 Billion | 4.97 Billion | 4.37 Billion |
| Operating Expenses | 2.6 Billion | 4.28 Billion | 3.78 Billion | 3.61 Billion | 3.94 Billion | 3.8 Billion |
| Selling, General and Administrative Expenses | 1.33 Billion | 961.5 Million | 849.9 Million | 830.9 Million | 915.9 Million | 1.1 Billion |
| Research and Development Expenses | - | 591.6 Million | 391.9 Million | 287.6 Million | 227 Million | - |
| Other Expenses | 348 Million | 2.1 Million | 4.6 Million | 2.1 Million | 4.7 Million | 2 Million |
| Cost and Expenses | 11.23 Billion | 8.54 Billion | 7.35 Billion | 6.92 Billion | 7.29 Billion | 6.5 Billion |
| Operating Income | 1.71 Billion | 1.5 Billion | 714.3 Million | 1.12 Billion | 1.03 Billion | 569.3 Million |
| Interest Expense | 12 Million | 6.3 Million | 9.5 Million | 10.9 Million | 11.4 Million | - |
| Income Tax Expense | 580.3 Million | 348.1 Million | 214.4 Million | 337.9 Million | 417.6 Million | 182.2 Million |
| Earnings before Tax | 2.19 Billion | 1.34 Billion | 830.4 Million | 1.27 Billion | 1.13 Billion | 726.7 Million |
| Net Income | 1.61 Billion | 992.9 Million | 616 Million | 933 Million | 722.1 Million | 544.5 Million |
| Earnings Per Share Basic | 64.60 | 39.72 | 24.64 | 37.32 | 28.88 | 21.78 |
| Earnings Per Share Diluted | 64.60 | 39.72 | 24.64 | 37.32 | 28.88 | 21.78 |
| Weighted Average Shares Outstanding | 25 Million | 25 Million | 25 Million | 25 Million | 25 Million | 25 Million |
| Weighted Average Shares Outstanding (Diluted) | 25 Million | 25 Million | 25 Million | 25 Million | 25 Million | 25 Million |
| Gross Margin | 0.48 | 0.58 | 0.56 | 0.59 | 0.60 | 0.62 |
| EBIT Margin | 0.18 | 0.19 | 0.12 | 0.18 | 0.16 | 0.12 |
| Profit Margin | 0.12 | 0.10 | 0.08 | 0.12 | 0.09 | 0.08 |
| EBITDA | 2.35 Billion | 1.5 Billion | 1 Billion | 1.47 Billion | 1.33 Billion | 875.9 Million |
| Earnings Before Tax Margin | 0.13 | 0.15 | 0.09 | 0.14 | 0.12 | 0.08 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 3.87 Billion | 3.83 Billion | 12.95 Billion | 3.05 Billion | 3.11 Billion | 2.95 Billion |
| Cost of Revenue | 2.95 Billion | 2.75 Billion | 8.5 Billion | 1.48 Billion | 1.22 Billion | 1.1 Billion |
| Gross Profit | 922.1 Million | 1.07 Billion | 4.44 Billion | 1.57 Billion | 1.88 Billion | 1.84 Billion |
| Operating Expenses | 580.5 Million | 622.82 Million | 2.75 Billion | 1.46 Billion | 1.39 Billion | 1.21 Billion |
| Selling, General and Administrative Expenses | 580.5 Million | 622.82 Million | - | 283.52 Million | 152.43 Million | 212.66 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 83.5 Million | 86.63 Million | 348 Million | 96.59 Million | 83.72 Million | 81.03 Million |
| Cost and Expenses | 3.53 Billion | 3.37 Billion | 11.26 Billion | 2.94 Billion | 2.61 Billion | 2.32 Billion |
| Operating Income | 341.6 Million | 456.24 Million | 1.69 Billion | 113.52 Million | 490.85 Million | 634.47 Million |
| Interest Expense | 1.1 Million | -656 Thousand | 12 Million | 6.12 Million | 5 Million | 1.53 Million |
| Income Tax Expense | -33.7 Million | 148.76 Million | 580.26 Million | 45.98 Million | 210.14 Million | 175.37 Million |
| Earnings before Tax | -151.6 Million | 543.53 Million | 2.19 Billion | 203.99 Million | 733.64 Million | 713.97 Million |
| Net Income | -117.9 Million | 394.78 Million | 1.61 Billion | 158 Million | 523.69 Million | 538.6 Million |
| Earnings Per Share Basic | -4.72 | 15.79 | - | 6.32 | 20.95 | 21.54 |
| Earnings Per Share Diluted | -4.72 | 15.79 | - | 6.32 | 20.95 | 21.54 |
| Weighted Average Shares Outstanding | 25 Million | 25 Million | 25 Million | 25 Million | 25 Million | 25 Million |
| Weighted Average Shares Outstanding (Diluted) | 25 Million | 25 Million | 25 Million | 25 Million | 25 Million | 25 Million |
| Gross Margin | 0.24 | 0.28 | 0.34 | 0.52 | 0.61 | 0.63 |
| EBIT Margin | 0.10 | 0.13 | - | 0.08 | 0.20 | 0.26 |
| Profit Margin | -0.03 | 0.10 | 0.12 | 0.05 | 0.17 | 0.18 |
| EBITDA | 380.7 Million | 493.88 Million | - | 247.16 Million | 611.32 Million | 753.49 Million |
| Earnings Before Tax Margin | 0.09 | 0.12 | 0.13 | 0.04 | 0.16 | 0.21 |
PANG
ATH-PA
603055
002673
HRMNYCP
3221